Tag: Heather Bresch
Attorneys the Big Winners in Mylan $264 Million EpiPen Price Gouging...
Settlement for consumers pales in comparison to the compensation Mylan execs received while the scheme was ongoing.
Viatris — Formerly Mylan — Agrees to $264 Million Settlement to...
Company does not admit to wrongdoing in settlement.
Politics and Greed: Who Benefited from the EpiPen Price Gouging Scandal?
"To get into something you don’t understand and your daughter being in this type of industry – it was best I stayed away."
Court Documents Show Mylan CEO Heather Bresch Played Integral Role in...
Bresch pressured counterpart at Pfizer to drop competing product.
Ruling Allows Millions to Join Lawsuit in EpiPen Racketeering Case
US District Judge Daniel Crabtree ruled numerous lawsuits against the marketer and manufacturer of EpiPen may proceed as a nationwide class-action under a federal racketeering statute.
Senator Blumenthal Demands Mylan Lower Price for Life-Saving Epipen
‘This is heartbreaking that I work full time and literally cannot afford this medication that would save my beautiful two year old,’ one Connecticut mother wrote the Senator.
Mylan, Marketer of EpiPen, to be Combined with Pfizer's Generics Business
Both companies are subject of a suit alleging an illegal scheme to increase sales of EpiPen.
Epinephrine Auto-Injector Companies Swept Up in 44 State Price Fixing Lawsuit
State prosecutors describe a price fixing scheme involving more than a dozen companies and as many executives responsible for sales, marketing, and pricing.
As EpiPen Company's Stock Plummets, CEO Heather Bresch Gets A Raise
You would think the CEO of a company whose stock lost 63% of its value would be shown the door. You would be wrong.
Senator to Introduce the 'Cure High Drug Prices Act' Spurred On...
“We’re talking about a workhorse drug. It is a matter of life and death for kids when they have emergency reactions."
